# Pyxis Oncology, Inc.: Form 8-K, filed Mar 23, 2026

- Company: [Pyxis Oncology, Inc.](/companies/pyxs.md) (CIK 1782223)
- Form: 8-K
- Filed: 2026-03-23
- Accepted by EDGAR: Mar 23, 2026, 07:12 ET
- Period: 2026-03-23
- Accession: 0001193125-26-118525
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1782223/000119312526118525/pyxs-20260323.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1782223/000119312526118525/

## Items reported

- Item 2.02: Results of operations
- Item 7.01: Regulation FD disclosure

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1782223/000119312526118525/pyxs-20260323.htm

Filed Mar 23, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-118525. Last ingested by Listed: Nov 14, 2026, 20:08 ET. No prices; not investment advice.
